
Ofeb Soft Capsules 100 mg (Nintedanib Ethanesulfonate)
120.4mg
Prescription medication
Boehringer Ingelheim Korea Co., Ltd.
Nintedanib esilate is an anti-fibrotic agent used to inhibit the progression of fibrosis in the treatment of pulmonary fibrosis.
MFDS ingredient code M118354
Nintedanib esilate is an anti-fibrotic agent that blocks the activity of tyrosine kinases of several growth factor receptors. It is primarily used to slow the progression of fibrosis in lung tissue. This ingredient plays a role in inhibiting abnormal cell proliferation and the fibrotic process within lung tissue.
Nintedanib esilate blocks the signaling of various growth factor receptors that promote fibrosis in lung tissue. This reduces excessive proliferation of fibroblasts and collagen accumulation, alleviating stiffness and damage to lung tissue. As a result, it has the effect of slowing the decline in lung function.
Approved uses differ by product. Check each product's information for its actual use.
Unlike other anti-fibrotic agents, Nintedanib esilate has a multi-target action that simultaneously inhibits several growth factor receptors. This allows it to effectively act on various fibrotic pathways, making it specialized for the treatment of pulmonary fibrosis. It is also classified as an antitumor agent and immunomodulator, offering the potential for combined therapeutic effects.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.